Abstract
A survey was carried out among EBMT (European Group for Blood and Marrow Transplantation) centres of the practical details of the prophylaxis and treatment of acute GVHD. The emphasis was on the prophylactic use of cyclosporine A and methotrexate and their combination, and on the initial treatment of acute GVHD. Eighty-seven centres sent a report. This survey demonstrated that marked differences exist between centres in the practices of GVHD prophylaxis and treatment despite superficially similar protocols. These differences may have an impact on the results obtained.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ruutu, T., Niederwieser, D., Gratwohl, A. et al. A survey of the prophylaxis and treatment of acute GVHD in Europe: a report of the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 19, 759–764 (1997). https://doi.org/10.1038/sj.bmt.1700745
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1700745
- Springer Nature Limited
Keywords
This article is cited by
-
Low cyclosporine concentrations in children and time to acute graft versus host disease
BMC Pediatrics (2020)
-
Effect of the severity of acute graft-versus-host disease on physical function after allogeneic hematopoietic stem cell transplantation
Supportive Care in Cancer (2020)
-
Retrospective analysis on transient recurrence of steroid-sensitive acute graft-versus-host disease
Bone Marrow Transplantation (2019)
-
Converting cyclosporine A from intravenous to oral administration in hematopoietic stem cell transplant recipients and the role of azole antifungals
European Journal of Clinical Pharmacology (2018)
-
Immunosuppression for in vivo research: state-of-the-art protocols and experimental approaches
Cellular & Molecular Immunology (2017)